UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 3, 2023 5:00 P.M.

Form:	S-1
CIK: 0001427570 Company Name: ReShape Lifesciences Inc. File Number: 333-269207